Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus

NCT05846347 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT05846347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05846347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus
Lead sponsor
Zhejiang University
Phase
Phase 1
Overall status
Unknown status
Start date
May 15, 2023
Completion date
April 19, 2025
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

car-t